Dr. Robert Lee Sullivan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Suite A, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-0840 |
Dr. Ann M Hoscheit, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 640 Summit Crossing Pl, Suite 202, Gastonia, NC 28054 Phone: 704-865-3937 |
Melissa Chen, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2555 Court Dr Ste 150, Gastonia, NC 28054 Phone: 704-864-7789 |
Accuvision Eye Care Od, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 3916 E Franklin Blvd Ste 160, Gastonia, NC 28056 Phone: 704-565-0660 Fax: 704-824-2192 |
Dr Kleinau And Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 246 N New Hope Rd, Gastonia, NC 28054 Phone: 707-867-1392 |
Dr. Ilan Moshe Dock, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 860 Summit Crossing Pl Ste 110, Gastonia, NC 28054 Phone: 704-865-3937 Fax: 704-865-8851 |
Dr. John Scott Mincey, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2396 E Franklin Blvd, Gastonia, NC 28054 Phone: 704-864-7878 |
Dr. Joseph Faulk, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 860 Summit Crossing Pl Ste 110, Gastonia, NC 28054 Phone: 704-865-3937 Fax: 704-865-8851 |
Dr. Rey Garrido, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-8029 |
Dr. Sara Elizabeth Toomey, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2555 Court Dr Ste 150, Gastonia, NC 28054 Phone: 704-864-7789 |
Myeyedr Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1302 E Garrison Blvd, Gastonia, NC 28054 Phone: 704-813-3113 |
Dr. Keith Pawlish Jr., O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3916 E Franklin Blvd Ste 160b, Gastonia, NC 28056 Phone: 704-565-0660 Fax: 704-824-2192 |
Gaston Eye Associates Optometrist Medicare: Medicare Enrolled Practice Location: 2325 Aberdeen Blvd, Ste A, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-0840 |
Audrey Grace Moore Optometrist Medicare: Medicare Enrolled Practice Location: 2555 Court Dr Ste 150, Gastonia, NC 28054 Phone: 704-864-7789 |
Fred S Cloninger, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 406 S Broad St, Suite A, Gastonia, NC 28054 Phone: 704-865-3731 Fax: 704-864-5736 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 860 Summit Crossing Pl Ste 110, Gastonia, NC 28054 Phone: 704-865-3937 |
Dr. Sandra L Farnham, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 640 Summit Crossing Pl, Suite 202, Gastonia, NC 28054 Phone: 704-865-3937 |
Doctors Vision Center Optometrist Medicare: Medicare Enrolled Practice Location: 2396 E Franklin Blvd, Gastonia, NC 28054 Phone: 704-864-7878 Fax: 704-868-9591 |
Dr. John Philip Foster, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd, Gastonia, NC 28054 Phone: 704-853-3937 Fax: 704-853-0840 |
Dr. Nima Mazhari, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2325 Aberdeen Blvd Ste A, Gastonia, NC 28054 Phone: 704-853-3937 |
News Archive
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism found that individuals with fatty liver were five times more likely to develop type 2 diabetes than those without fatty liver. This higher risk seemed to occur regardless of the patient's fasting insulin levels, which were used as a marker of insulin resistance.
International aid groups are "scrambling to engage members of Congress and the American public in a dialogue about the need to secure U.S. foreign assistance funding" as the "next deadline for the U.S. Congress to pass a full fiscal year 2011 budget or another short-term continuing resolution is fast approaching" and discussions on the FY12 budget need to begin, the Devex blog "Obama's Foreign Aid Reform" reports.
MEI Pharma, Inc., an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers.
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
› Verified 3 days ago